EnWave Signs Collaboration Agreement with Cherry Central Cooperative Inc.

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company")
announced today it has signed a Collaboration Agreement (the "Agreement") with
Cherry Central Cooperative Inc. ("Cherry Central"), an industry leader in the
production and processing of red tart cherries, amongst other fruits and
vegetables, in the United States of America. 


Cherry Central has successfully completed an initial evaluation and plans to
expand its testing of EnWave's Radiant Energy Vacuum ("REV") technology. The
goal of the Collaboration is to facilitate a broader product development and
market assessment for a premium dehydrated cherry snack product with superior
flavor, color and nutritional value than currently available in the market. In
addition to the snack market, Cherry Central also plans to evaluate new
opportunities for cherry and apple powders to be positioned as an alternative to
conventional fruit purees. Under the terms of the Agreement Cherry Central has
the option to license the Company's REV technology for the production of red
tart cherries and apple powders for commercial distribution. All other terms of
the Agreement are confidential. 


"The interest in our REV technology from current and potential partners has
intensified since commercial production of healthy berry snacks and powders
recently started at the first industrial scale licensed plant in the United
States," stated Dr. Tim Durance, Chairman & Co-CEO of EnWave. "Attracting the
attention of and partnering with a market leader like Cherry Central will
provide EnWave with another tangible opportunity to help bring new tasty,
healthy innovative products to market."


"Cherry Central has been a leader in the production, processing and distribution
of fruit and vegetable products for over four decades," stated Mr. Steve
Eiseler, President of Cherry Central. "Our continued goal is to supply the
market with products of superior taste, texture and appearance - three
attributes that REV technology could potentially enhance." 


About Cherry Central Cooperative Inc. 

Established in 1973, Cherry Central Cooperative Inc. is the industry leader in
red tart cherries, apples and blueberries and is also a major supplier of
cranberries, strawberries, pomegranate arils and asparagus grown on farms across
the United States, Canada and worldwide. Working with their member cooperatives,
they grow, harvest and process fruit and vegetables to form a vertically
integrated operation. The total average production of tart cherries in the U.S.
is between 250,000,000 and 300,000,000 lbs per year and Cherry Central is one of
the largest single suppliers of the product in the United States. 


About EnWave 

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV)
dehydration technology. The Company recently licensed REV technology to Milne
Fruit Products Inc, its first major U.S. customer, to support a launch of
healthy berry snacks and powders across most major markets in North America.
More recently, EnWave licensed REV technology to one of its Tier 1 multinational
partners from the list below. In addition, EnWave has entered a wide range of
research and collaboration agreements with an expanding list of multinational
partners, including Nestle, Kellogg's, Grupo Bimbo, Grimmway Farms, Ocean Spray
Cranberries, Hormel, Bonduelle and Merck. EnWave is introducing REV as a new
dehydration standard in the food and biological material sectors: potentially
faster and cheaper than freeze drying, with better end product quality than air
drying or spray drying.


EnWave currently has six REV platforms: commercial-scale nutraREV(R) and
MIVAP(R) are used in the food industry to dry fruits, vegetables, meat, herbs
and seafood quickly and at low-cost, while maintaining high levels of nutrition,
taste, texture and colour. The Company is also developing powderREV(TM) for bulk
dehydration of food cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of pastes,
gels, liquids, or particulates; and bioREV(TM) and freezeREV(TM) as new methods
to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies.
More information about EnWave is available at www.enwave.net.


EnWave Corporation 

Dr. Tim Durance, Chairman & Co-CEO 

Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the Company's strategy
for growth, product development, market position, expected expenditures and
financial results are forward-looking statements. These statements are not a
guarantee of future performance and involve a number of risks, uncertainties and
assumptions. There is no guarantee that the Company's REV technology can or will
improve processes in the target industry; even if the Company's REV technology
can be used as described in this document, there is no guarantee that such use
will result in orders for the Company's REV technology. All figures comparing
REV technologies to freeze drying or other dehydration technologies are provided
as examples of data obtained through the Company's own scientific and testing
programs; each product must be tested individually to determine the benefits of
using REV.
(TSXV:REV)
過去株価チャート
から 5 2024 まで 6 2024